We’re thrilled to announce our lab's latest publication in Expert Opinion on Biological Therapy, where we present a comprehensive review of emerging peptide-based technologies for biofilm control. Our review explores the immense potential of antibiofilm peptides (ABPs) as a promising solution to combat biofilm-related infections, which are increasingly resistant to traditional antibiotic treatments.
We believe our review offers an expert perspective on the challenges and opportunities in ABP development. While highlighting the promising potential of ABPs, we also address the critical gap between laboratory discoveries and clinical applications. The paper emphasizes the need for simultaneous advancements in ABP design, testing methods, and delivery systems to bridge this gap and accelerate the development of effective treatments for biofilm-related infections.
For a deeper dive into our findings, you can access the complete publication in Expert Opinion on Biological Therapy at Taylor & Francis Online: Emerging Peptide-Based Technology for Biofilm Control.
We’re excited to push the boundaries of biofilm control and look forward to the potential impact of these technologies on healthcare and public health.
תגובות